Covered recipient · General Payments record
CINDY A KELLY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2023
$4,870.40
- Reported across 329 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $258.76 | 14 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $81.91 | 4 |
| ABBVIE INC. | $55.07 | 3 |
| Acerta Pharma LLC | $43.80 | 3 |
| Exact Sciences Corporation | $42.23 | 2 |
| DEXCOM, INC. | $22.96 | 1 |
| Novo Nordisk AS | $12.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.43 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997624247 | CMS |
| ABBVIE INC. | $14.43 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997624249 | CMS |
| ABBVIE INC. | $25.21 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997624251 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.71 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011936797 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.72 | 05/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015772865 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.37 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011255499 | CMS |
| Dexcom, Inc. | $22.96 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054670497 | CMS |
| Exact Sciences Corporation | $22.04 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026582140 | CMS |
| Exact Sciences Corporation | $20.19 | 04/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026582203 | CMS |
| Lilly USA, LLC | $18.59 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031339537 | CMS |
| Lilly USA, LLC | $20.40 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031323817 | CMS |
| Lilly USA, LLC | $18.04 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031336387 | CMS |
| Lilly USA, LLC | $24.88 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031441491 | CMS |
| Novo Nordisk Inc | $12.79 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000522277 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.